Adagene News

Express News | Adagene Inc : Jefferies Cuts Target Price to $8 From $26

ReutersJun 7 01:43 ET

12 Health Care Stocks Moving In Friday's After-Market Session

GainersLiquidia (NASDAQ:LQDA) stock rose 12.7% to $14.5 during Friday's after-market session. The market value of their outstanding shares is at $1.1 billion. Adagene (NASDAQ:ADAG) shares moved upward

BenzingaMay 31 16:32 ET

Adagene to Present at Investor Conferences in June

Adagene Inc. ("Adagene") (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced its participation in multiple investor conferences in June 2024.

GlobeNewswireMay 22 16:45 ET

Analysts Offer Insights on Healthcare Companies: EFFECTOR Therapeutics (EFTR), Adagene (ADAG) and Aquestive Therapeutics (AQST)

TipRanksApr 5 06:30 ET

12 Health Care Stocks Moving In Monday's Intraday Session

GainersSunshine Biopharma (NASDAQ:SBFM) stock rose 86.3% to $0.11 during Monday's regular session. The company's market cap stands at $11.2 million. Xilio Therapeutics (NASDAQ:XLO) stock rose 25.93% t

BenzingaApr 1 12:31 ET

Adagene Inc. Strikes Deal to Sell Depositary Shares

TipRanksMar 29 15:57 ET

Adagene ADR Non-GAAP EPS of -$0.21, Revenue of $18.11M

Seeking AlphaMar 29 12:47 ET

Adagene's Breakthroughs Promise Future Growth

TipRanksMar 29 09:57 ET

TianYan Pharmaceutical announced that it will attend the 2024 Leerink Partners Global Biomedical Conference

Suzhou, China and San Diego, USA, Feb. 28, 2024/PRNewswire/ -- Tianyan Pharmaceutical (“Company” or “Tianzhan”) (NASDAQ: ADAG) is a platform-driven clinical-stage biopharmaceutical company dedicated to discovering and developing novel therapeutics based on original antibodies. The company announced today that it will attend the Leerink Partners Global (the Leerink Partners Global) 2024 to be held in Miami, Florida, USA from March 11 to 13

PR NewswireFeb 27 18:00 ET

Adagene to Present at the Leerink Partners Global Biopharma Conference 2024

SAN DIEGO and SUZHOU, China, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. ("Adagene") (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today

AdageneFeb 27 00:00 ET

Pharma Giants Turn to China in Search of Targeted Cancer Drugs

Seeking AlphaFeb 4 12:00 ET

Redhill Biopharma, Vera Therapeutics Among Healthcare Movers

Seeking AlphaJan 25 10:00 ET

12 Health Care Stocks Moving In Monday's After-Market Session

GainersCadrenal Therapeutics (NASDAQ:CVKD) shares moved upwards by 8.5% to $1.15 during Monday's after-market session. The market value of their outstanding shares is at $14.9 million. vTv Therapeutic

BenzingaJan 22 16:31 ET

Analysts Conflicted on These Healthcare Names: Abbott Labs (ABT), Adagene (ADAG) and Teleflex (TFX)

TipRanksJan 22 12:10 ET

CRGE and LAES Among Mid-day Movers

Seeking AlphaJan 19 12:42 ET

Accelerate Diagnostics, Silk Road Medical Among Healthcare Movers

Seeking AlphaJan 19 09:59 ET

Cano Health, DarioHealth Among Healthcare Movers

Seeking AlphaJan 18 10:00 ET

NCAC, PTPI and CTSO Among Pre-market Losers

Seeking AlphaJan 18 08:24 ET

12 Health Care Stocks Moving In Thursday's Pre-Market Session

GainersCelularity (NASDAQ:CELU) shares rose 43.4% to $0.27 during Thursday's pre-market session. The company's market cap stands at $52.3 million. Kronos Bio (NASDAQ:KRON) stock moved upwards by 33.64

BenzingaJan 18 08:05 ET

How Is The Market Feeling About Adagene?

Adagene's (NYSE:ADAG) short percent of float has fallen 20.0% since its last report. The company recently reported that it has 25 thousand shares sold short, which is 0.08% of all regular shares that

BenzingaJan 18 08:00 ET